Neovasc (NVCN) Stock Price, News & Analysis

Company Overview

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 399 shs
• Average Volume: 2,123 shs
• Market Capitalization: C$110.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Industrials
• Industry: Surgical & Medical Instrument Manufacturing
• Sub-Industry: Medical Equipment
• Current Symbol: TSE:NVCN
• CIK: N/A
• Web: www.neovasc.com
• Phone: 16042704344
• Fax: N/A
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($20.44)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$33.52 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -78.25%
• Return on Assets: -32.95%

Debt

• Debt-to-Equity Ratio: 44.86
• Current Ratio: 8.44
• Quick Ratio: 8.04

Sales & Book Value

• Annual Sales: C$3.11 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 1.05
• Book Value: C$10.22 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,760,000
• Free Float: N/A
• Market Cap: C$110.81 million
• Optionable: Not Optionable
• Beta: 2.01